These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7095119)

  • 1. [Kinetics of dihydralazine].
    Siegmund WS; Huller H; Franke H; Kallwellis R; Lupke A
    Farmakol Toksikol; 1982; 45(3):105-7. PubMed ID: 7095119
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydralazine therapy and acetylator phenotype.
    Iisalo E; Laine T; Lehtonen A; Sellman R
    Int J Clin Pharmacol Biopharm; 1979 Mar; 17(3):119-24. PubMed ID: 429082
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of the acetylator phenotype for the clinical use of dihydralazine.
    Siegmund W; Franke G; Biebler KE; Donner I; Kallwellis R; Kairies M; Scherber A; Hüller H
    Int J Clin Pharmacol Ther Toxicol; 1985 Apr; 23 Suppl 1():S74-8. PubMed ID: 3842694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Quantitative determination and kinetics of dihydralazine in hypertension patients].
    Siegmund W; Zschiesche M; Kallwellis R; Franke G; Schneider T; Sill U; Scherber A; Hüller H
    Pharmazie; 1985 Nov; 40(11):779-81. PubMed ID: 4095128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Blood pressure effects of selected dihydralazine metabolites].
    Schröder LW; Siegmund W; Schneider T; Lohberg S; Grisk A
    Pharmazie; 1986 Jun; 41(6):439. PubMed ID: 3763688
    [No Abstract]   [Full Text] [Related]  

  • 6. [Ergometric studies for supplementary evaluation of antihypertensive therapy].
    Franz IW; Lohmann FW
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():325-7. PubMed ID: 347807
    [No Abstract]   [Full Text] [Related]  

  • 7. [A cross-over comparison of dihydralazine and minoxidil in severe hypertension (author's transl)].
    Rumboldt Z; Jurisić M; Bagatin J
    Lijec Vjesn; 1982 Feb; 104(2):64-8. PubMed ID: 7050574
    [No Abstract]   [Full Text] [Related]  

  • 8. [The quantitative identification of metabolites of dihydralazine in the human].
    Schneider T; Siegmund W; Zschiesche M; Kallwellis R; Scherber A
    Pharmazie; 1988 Jan; 43(1):33-6. PubMed ID: 3375299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of dihydralazine infusion on the fetoplacental blood flow and maternal prostanoids.
    Jouppila P; Kirkinen P; Koivula A; Ylikorkala O
    Obstet Gynecol; 1985 Jan; 65(1):115-8. PubMed ID: 3838110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions of dihydralazine with furosemide in hypertonic patients.
    Siegmund W; Kairies M; Franke G; Donner I; Biebler KE
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):148-51. PubMed ID: 3557742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of oxprenolol, triamterene, and dihydralazine in the treatment of essential hypertension].
    Gerc V; Numić N
    Med Arh; 1980; 34(1):51-9. PubMed ID: 7007752
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of low-dose dihydrallazine on the fetus in the emergency treatment of hypertension in pregnancy.
    Vink GJ; Moodley J
    S Afr Med J; 1982 Sep; 62(14):475-7. PubMed ID: 7123405
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dihydralazine and catecholamine-synthesizing enzymes in spontaneous hypertension.
    Denoroy L; Renaud B; Vincent M; Sacquet J; Sassard J
    Eur J Pharmacol; 1979 Sep; 58(2):207-10. PubMed ID: 499352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebrovascular effects of dihydralazine in hypertensive and normotensive rats.
    Auer LM; Sayama I; Johansson BB
    Acta Med Scand Suppl; 1983; 678():73-81. PubMed ID: 6584015
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hypertension with a drug combination, consisting of bemetizide, triamterene, dihydralazine and bupranolol (author's transl)].
    Gasser RW; Brandstetter G; Skrabal F
    Wien Klin Wochenschr; 1982 Jan; 94(1):25-8. PubMed ID: 7080491
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Dihydralazine and intracranial pressure. Risks in the treatment of patients with space-occupying, intracranial processes].
    Dahlerup B; Laursen J
    Ugeskr Laeger; 1987 Sep; 149(39):2589-91. PubMed ID: 3451489
    [No Abstract]   [Full Text] [Related]  

  • 17. [Can lupus be caused by dihydralazine?].
    Fakri E; François B
    Nouv Presse Med; 1979 Nov; 8(45):3754. PubMed ID: 534238
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of cardiovascular actions of dihydralazine, phentolamine, and prazosin in spontaneously hypertensive rats.
    Lefèvre-Borg F; Roach AG; Cavero I
    J Cardiovasc Pharmacol; 1979; 1(1):19-29. PubMed ID: 94378
    [No Abstract]   [Full Text] [Related]  

  • 19. Blood pressure response and renin release following 4 days of treatment with dihydralazine and urapidil in conscious dogs.
    Bacher S; Kraupp O; Beck A; Seitelberger R; Raberger G
    Cardiovasc Res; 1984 Feb; 18(2):67-74. PubMed ID: 6365312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergency treatment of severe hypertension evaluated in a randomized study. Effect of rest and furosemide and a randomized evaluation of chlorpromazine, dihydralazine and diazoxide. Danish Multicenter Study.
    Acta Med Scand; 1980; 208(6):473-80. PubMed ID: 7468317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.